ObsEva Competitors and Similar CompaniesClear all

Durect's competitors and similar companies include Affimed N.V. and Amicus Therapeutics.

	Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.	Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.	Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Founding Date	Founding Date N/A	Founding Date 2000	Founding Date 2002
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma
Locations	Locations Cupertino, US HQ	Locations Heidelberg, DE HQ	Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more
Employees	Employees 902% increase	Employees 76	Employees 58415% increase
Valuation ($)	Valuation ($) 45.3 m	Valuation ($) 52.5 m	Valuation ($) 3.4 b
Financial
Revenue (est.)	Revenue (est.) $2m (FY, 2024)	Revenue (est.) €8.3m (FY, 2023)	Revenue (est.) $634.2m (FY, 2025)
Cost of goods	Cost of goods $78k (FY, 2024)	Cost of goods N/A	Cost of goods $72.9m (FY, 2025)
Gross profit	Gross profit $2m (FY, 2024)	Gross profit €13m (FY, 2023)	Gross profit $561.3m (FY, 2025)
Net income	Net income ($8.3m) (FY, 2024)	Net income (€105.9m) (FY, 2023)	Net income ($27.1m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 20m	Total funding raised N/A	Total funding raised $ 88m